Rats selectively bred for low aerobic capacity have reduced hepatic mitochondrial oxidative capacity and susceptibility to hepatic steatosis and injury by Thyfault, John P. et al.
J Physiol 587.8 (2009) pp 1805–1816 1805
Rats selectively bred for low aerobic capacity have reduced
hepatic mitochondrial oxidative capacity and susceptibility
to hepatic steatosis and injury
John P. Thyfault1,2,3, R. Scott Rector2, Grace M. Uptergrove2, Sarah J. Borengasser3, E. Matthew Morris2,3,
Yongzhong Wei2, Matt J. Laye4, Charles F. Burant6, Nathan R. Qi6, Suzanne E. Ridenhour2,
Lauren G. Koch5, Steve L. Britton5 and Jamal A. Ibdah1,2,4
1Harry S. Truman Memorial VA Hospital, Research Service, Columbia, MO 65201, USA
2Departments of Internal Medicine—Division of Gastroenterology and Hepatology, 3Nutritional Sciences and 4Medical Pharmacology and Physiology,
University of Missouri, Columbia, MO 65211, USA
Departments of 5Physical Medicine and Rehabilitation and 6 Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA
Fatty liver has been linked to low aerobic fitness, but the mechanisms are unknown. We
previously reported a novel model in which rats were artificially selected to be high capacity
runners (HCR) and low capacity runners (LCR) that in a sedentary condition have robustly
different intrinsic aerobic capacities. We utilized sedentary HCR/LCR rats (generation 17;
max running distance equalled 1514 ± 91 vs. 200 ± 12 m for HCR and LCR, respectively) to
investigate if low aerobic capacity is associated with reduced hepatic mitochondrial oxidative
capacity and increased susceptibility to hepatic steatosis. At 25 weeks of age, LCR livers displayed
reduced mitochondrial content (reduced citrate synthase activity and cytochrome c protein) and
reduced oxidative capacity (complete palmitate oxidation in hepatic mitochondria (1.15 ± 0.13
vs. 2.48 ± 1.1 nm g−1 h, P < 0.0001) and increased peroxisomal activity (acyl CoA oxidase and
catalase activity) compared to the HCR. The LCR livers also displayed a lipogenic phenotype
with higher protein content of both sterol regulatory element binding protein-1c and acetyl
CoA carboxylase. These differences were associated with hepatic steatosis in the LCR including
higher liver triglycerides (6.00 ± 0.71 vs. 4.20 ± 0.39 nmol g−1, P = 0.020 value), >2-fold higher
percentage of hepatocytes associated with lipid droplets (54.0 ± 9.2 vs. 22.0 ± 3.5%, P = 0.006),
and increased hepatic lipid peroxidation compared to the HCR. Additionally, in rats aged to
natural death, LCR livers had significantly greater hepatic injury (fibrosis and apoptosis). We
provide novel evidence that selection for low intrinsic aerobic capacity causes reduced hepatic
mitochondrial oxidative capacity that increases susceptibility to both hepatic steatosis and liver
injury.
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Non-alcoholic fatty liver disease (NAFLD) encompasses
a gamut of liver maladaptations and is a primary cause
of chronic liver disease and liver-related morbidity and
mortality. Fatty liver occurs at a higher rate in individuals
with obesity and type 2 diabetes and is considered
the hepatic component of the metabolic syndrome
(Schindhelm et al. 2006). Currently, 34% of the general
population (Browning et al. 2004) and 75–100% of obese
and extremely obese individuals are estimated to have fatty
liver (Bellentani et al. 2000).
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Low aerobic capacity, or low cardiorespiratory fitness,
is the strongest predictor of early mortality (Myers et al.
2002). Aerobic capacity is dependent upon the ability of
the cardiorespiratory system to deliver oxygen and the
capacity of mitochondria to utilize oxygen for energy
production. In the absence of exercise training, it is
believed that genetic inheritance accounts for up to 70%
of the variation in intrinsic aerobic capacity (Bouchard
et al. 1986). In most cases, exercise training significantly
improves aerobic capacity; however, exercise-induced
responses are grossly heterogeneous (Kohrt et al. 1991;
Bouchard & Rankinen, 2001). Recent evidence also links
low aerobic capacity (Nguyen-Duy et al. 2003; Church et al.
2006; McMillan et al. 2007) to an increased deposition
of fat in the liver; however, there is no mechanistic
information detailing these connections.
Over several generations of selective breeding for high
and low treadmill endurance running (performance on
3 graded exercise tests), we have developed two strains
of rats with grossly different intrinsic endurance exercise
capacities (max run distance during a graded exercise test
to exhaustion is ∼7-fold different) and aerobic capacities
(30% different at generation 11) (Wisloff et al. 2005). This
novel animal model is valuable to study the interaction
between aerobic capacities and chronic disease for two
main reasons: (1) the contrasting aerobic capacities occur
in a sedentary, caged-activity-only condition (Hoydal
et al. 2007) removing the conflicting effects of daily
exercise training (Wisloff et al. 2005; Bernal-Mizrachi
& Semenkovich, 2006); and (2) the strains are a
polygenic model of disease that more accurately mimics
the pathology of human chronic metabolic disease(s) than
single gene mutations. At generation 11, the sedentary low
capacity runners (LCR) displayed a higher incidence of
both cardiovascular and metabolic syndrome risk factors
than sedentary high capacity runners (HCR) (Wisloff
et al. 2005). In addition, at generation 13, LCR rats were
susceptible to high-fat diet induced obesity and insulin
resistance while the HCR rats were largely unaffected
(Noland et al. 2007a). In both reports, skeletal muscle
mitochondrial oxidative capacity, which is high in the
muscle of HCR, and low in the muscle of LCR, was
hypothesized to be the primary cause for protection or
susceptibility to metabolic dysfunction, respectively.
In the current study, we investigate the potential links
between intrinsic aerobic capacity, hepatic mitochondrial
oxidative capacity and susceptibility to hepatic steatosis
in generation 17 HCR and LCR rats. Importantly, these
studies occurred in sedentary rats which are genetically
predisposed to high and low aerobic capacities allowing for
the determination of hepatic metabolism independently
of the effects of exercise training. We hypothesize that
the phenotype of low aerobic capacity is associated with
both reduced hepatic mitochondrial content and oxidative
capacity which increases both susceptibility to early life
hepatic steatosis and significant hepatic injury at an older
age.
Methods
Animal strain and protocols
The development of LCR and HCR rats has previously
been described (Wisloff et al. 2005; Noland et al. 2007a).
Briefly, two-way artificial selective breeding was used to
create low capacity runner (LCR) and high capacity runner
(HCR) strains that were divergent for treadmill running
capacity (run time to exhaustion on a graded exercise test).
The founder population (N : NIH stock) and generation
of the HCR and LCR strains has been previously reported
(Wisloff et al. 2005). In brief, the 13 lowest and 13
highest running capacity rats of each sex were selected
from the founder population and randomly paired for
mating. At each subsequent generation, within-family
selection from 13 mating pairs was practiced for each
line, a number of families that maintains a relatively
low coefficient of inbreeding (<0.01/generation) and
maximizes the retention of genetic variation. After the
rats were phenotyped for running capacity they were
exposed to no further exercise training or testing and only
underwent normal cage activity.
The animal protocols were approved by the Institutional
Animal Care and Use Committees at the University of
Missouri and the University of Michigan and the Sub-
committee for Animal Safety at the Harry S. Truman
Memorial VA Hospital.
Two separate sets of ∼25-week-old male LCR (n = 7)
and HCR (n = 8) rats from generation 17 were used
for the investigation of hepatic steatosis and hepatic
mitochondrial oxidative capacity. The rats arrived at
∼14 weeks of age, were provided standard rat chow and
water ad libitum, and were kept on a 12 h light–12 h dark
time schedule until killed at ∼25 weeks of age. On the
morning of tissue collection, rats were intraperitoneally
injected with sodium Nembutal (100 mg kg−1), blood was
collected, the animals were exsanguinated, and tissues were
frozen with liquid nitrogen and stored at –80◦C or fixed for
immunohistochemistry. Tissue was collected in the same
manner in a second group of 25-week-old, generation 17,
HCR (n = 8) and LCR (n = 8) rats and ∼500 mg of liver
was quickly removed and placed in ice-cold buffer for
the isolation of hepatic mitochondria or frozen for later
measurement of peroxisomal enzyme activity. Additional
generation 17 rats (HCR, n = 4; LCR, n = 6) were aged
until natural death or until they were killed because
of undue suffering at approximately 24–35 months of
age at the University of Michigan where the rats were
generated. After death animals underwent necropsy within
4 h and livers were fixed for immunohistochemistry only.
Weekly food consumption and changes in body weight
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were measured in an additional set of HCR/LCR rats
(n = 10 in both groups) from 5 to 25 weeks of age. In
addition, determinations of physical activity and oxygen
consumption by indirect calorimetry were taken in the
rats over a 2 day period at 25 weeks of age.
Intrahepatic lipid content
Hepatic triglycerides (TAG) were measured as referenced
previously using a commercially available kit (Sigma,
F6428) (Rector et al. 2008).
Histology analysis
Liver and epididymal adipose tissues were collected and
fixed in 10% formalin for histological analysis. Routine
hematoxylin–eosin (H&E) staining was performed in both
liver and adipose and sirius red staining for collagen
deposition was performed in paraffin liver sections
as previously referenced (Wei et al. 2008). Hepatic
steatosis and the percentage of hepatocytes associated with
lipid droplets were determined as referenced previously
(Ibdah et al. 2005) and morphometric determinations
of adipocyte cell volume were carried out as previously
referenced (Laye et al. 2006).
Immunohistochemistry
Liver paraffin sections were de-paraffinized and
non-specific antibody binding was blocked with 5%
normal goat or rabbit serum and 5% BSA in
phosphate-buffered saline (PBS). These sections were
incubated with anti-carbamoylphosphate synthetase 1
(CPS1), transforming growth factor β (TGF-β) or
4-hydroxynonenal (4-HNE) antibodies at 1 : 200 dilutions
for overnight at 4◦C. After washing, the sections were
incubated with a second antibody conjugated with
alexa-586 for 1 h at room temperature and mounted
with DAPI (Vector) or biotin conjugated second anti-
body, following by 0.3% H2O2, ABC (Vector), NovaRed
(Vector), and counterstained with hematoxylin. The
primary antibody was omitted from this procedure for
additional sections to ensure that results were not due to
non-specific binding. Images were acquired with a light
and fluorescence microscope (Nikon, Eclipse 50i).
Apoptosis by TUNEL staining
To evaluate apoptotic cell death, terminal
desoxynucleotide transferase-mediated dUTP nick
end labelling (TUNEL) was performed in liver sections
using an in situ Apoptosis Detection Kit (Roche Applied
Science, Indianapolis, IN, USA) as per the manufacturer’s
instructions. TUNEL-positive and -negative nuclei were
counted at five random fields for each section. Results are
expressed as number of TUNEL-positive cell/total cells ×
100%.
Western blotting
Peroxisome proliferator-activated receptor (PPAR) γ,
PPARα, and sterol regulatory binding protein-1c
(SREBP-1c) antibodies were purchased from Santa Cruz
Biotechnology, Inc. (Santa Cruz, CA, USA). Antibodies
against Acetyl CoA carboxylase (ACC) and cytochrome
c were obtained from Cell Signaling Technology, Inc.
(Beverly, MA, USA) and 4-HNE was purchased from
Oxis International Inc. (Beverly Hills, CA, USA). Liver
samples were homogenized in ice cold buffer, separated
by SDS-PAGE gels, transferred to PVDF membranes and
probed with primary antibodies. Protein bands were
quantified using a densitometer and band densities were
corrected for total protein loaded by staining with 1%
amido-black (Sigma) as described previously (Rector et al.
2008).
Hepatic mitochondrial enzyme activities, isolation,
and palmitate oxidation
Citrate synthase and β-hydroxyacyl-CoA dehydrogenase
(β-HAD) activity were both measured as previously
described in whole liver homogenates (Rector et al. 2008).
Mitochondrial suspensions were prepared according to
modified methods of Koves et al. (2005). A portion of
the liver was quickly excised from unconscious rats and
placed in 5 ml of fresh Buffer A (100 mM KCl, 50 mM
Mops, 5 mM MgSO4, 1 mM EGTA, 1 mM ATP, pH 7.4).
The liver was then minced and suspended 7-fold (w/v)
in Buffer A, and homogenized for 15 s. The homogenate
was then centrifuged at 800 g for 10 min at 4◦C and the
supernatant was filtered through gauze and set aside. The
remaining pellet was resuspended in Buffer A, homo-
genized, and the homogenate was then centrifuged at
800 g for 10 min at 4◦C. The remaining supernatant
was added to the previously set aside supernatant after
filtering through gauze. The pooled supernatants were
centrifuged at 9000 g to pellet the mitochondria. The
pellet was resuspended in Buffer B (Buffer A, 0.2% BSA,
pH 7.4), and centrifuged at 8000 g before the pellet
was washed and resuspended in Buffer C (100 mM KCL,
50 mM Mops, 0.5 mM EGTA, pH 7.4) and centrifuged for
10 min at 7000 g . The final pellet was resuspended in
0.5 ml of sucrose EDTA (SET) buffer and protein content
was determined. Palmitate oxidation was measured with
radiolabelled [1-14C]palmitate (American Radiolabeled
Chemicals, Inc., St Louis, MO, USA) in the freshly
isolated liver mitochondria preparation using methods
previously reported (Laye et al. 2008; Rector et al. 2008).
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Both 14CO2, representing complete fatty acid oxidation,
and 14C labelled acid soluble metabolites, representing
incomplete fatty acid oxidation, were collected in the
previously described trapping device and then counted on
a liquid scintillation counter. In addition to [14C]palmitate
the reaction buffer contained a final concentration of
50 μM cold palmitate and 0.5% BSA.
Hepatic peroxisomal enzyme activity
Acyl-CoA oxidase activity was determined using a
modification of methods previously described (Small
et al. 1985). Briefly, H2O2 production was measured
spectrophotometrically (520 nm) through oxidative
coupling with 3,5-dichloro-2-hydroxybenzenesulfonic
acid to 4-aminoantipyrine in the presence of horse-
radish peroxidase. Reaction wells contained 20 μl
of liver homogenate and 200 μl of reaction
buffer consisting of 40 mM aminotriazole, 0.02%
Triton X-100, 0.5 mM 4-aminoantipyrine, 4 mM
3,5-dichloro-2-hydroxybenzenesulfonic acid, 8 U horse-
radish peroxidase, 11 mM potassium phosphate; pH 7.4.
They were incubated for 5 min at 37◦C. The reaction
was initiated by the addition of acyl-CoA substrate
(50 μM) and absorbance was monitored continuously
over 30 min at 37◦C. Catalase activity was determined by
the spectrophotometric (520 nm) oxidative coupling of
3,5-dichlorobenzene-sulfonic acid to 4-aminoantipyrine
in the presence of HRP and H2O2 (Sigma) as previously
described (Noland et al. 2007b).
Serum assays and blood pressure
Serum TAG (Sigma) and insulin (Linco Research, St
Charles, MO, USA) were measured using commercially
available kits. Serum alanine aminotransferase (ALT)
concentrations were determined utilizing an Olympus
AU400e Chemistry Immuno Analyzer (Olympus America,
Inc., Center Valley, PA, USA). Systolic blood pressure was
measured in triplicate using the tail-cuff method a week
before sacrifice.
Food consumption, ambulatory physical activity,
and oxygen consumption
Both ad libitum food consumption and total body
weights were measured every week from the post-weaning
period (∼5 week) until 25 weeks of age. In addition,
oxygen consumption (V̇O2 ), carbon dioxide production
(V̇CO2 ), and spontaneous motor activity were measured
using a Comprehensive Laboratory Monitoring System
(CLAMS, Columbus Instruments, Columbus, OH, USA)
over a 2 day period at 25 weeks of age at the
University of Michigan Animal Phenotyping Core. The
Table 1. Characteristics LCR and HCR rats at 25 weeks of age
Variable LCR HCR
Body weight (g) 497 ± 48∗ 350 ± 28
Max run distance at 11 weeks (m) 188 ± 15∗ 1486 ± 86
Serum insulin (ng ml−1) 3.03 ± 0.44∗ 1.34 ± 0.24
Serum TAG (mg dl−1) 61.1 ± 19.5∗ 16.7 ± 1.8
Serum ALT (U l−1) 61.1 ± 14.1 57.4 ± 38.4
Systolic blood pressure (mmHg) 160.2 ± 2.3∗ 151.1 ± 1.3
Means ± S.E.M. ∗Significantly different from HCR, P < 0.05;
m, metres.
measurements were carried out continuously for 48 h in
an experimentation room set at 20–23◦C with 12–12 h
(18.00 h∼06.00 h) dark–light cycles. V̇O2 and V̇CO2 in each
chamber were sampled sequentially for 5 s in a 5 min
interval and the motor activity was simultaneously
recorded every second in X and Z dimensions. The air
flow rate through the chambers was adjusted at the level
to keep the oxygen differential around 0.3% at resting
conditions.
Statistics
For each outcome measure, a one-way analysis of variance
was performed using SPSS 15.0 (Chicago, IL, USA).
Pearson correlational analysis was also used on select data.
Values are reported as means ± S.E.M., and a P value <
0.05 was considered statistically significant.
Results
Animal characteristics
The HCR rats ran ∼9-fold further distance (P < 0.001)
than LCR rats during the graded exercise test conducted
at 11 weeks of age (Table 1). In the rats killed at
25 weeks, the LCR rats displayed overt characteristics of
the metabolic syndrome compared to the HCR including
heavier body weights, elevated serum TAG (P = 0.045)
and insulin (P = 0.005) and higher systolic blood
pressures (P = 0.039) (Table 1). Serum ALT levels, a
marker of liver injury, were not significantly different
between groups (Table 1).
Ambulatory physical activity, oxygen consumption
and food consumption
At 25 weeks of age, the LCR rats had 40% lower ambulatory
physical activity in the 12 h dark phase (P < 0.001) and a
22% lower activity in the light phase (P = 0.008) compared
to the HCR (Table 3). This corresponded with a 16%
and 11% lower total oxygen consumption in both the
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light (P = 0.005) and dark phase (P < 0.001), respectively
(Table 3). Average weekly food consumption (averaged
from ∼4 to 25 weeks of age) was also significantly lower
in the LCR rats (P = 0.03) (Table 3). Collectively, these
data indicate that the contrasting levels of ambulatory
activity and oxygen consumption measured between the
two strains corresponded with different rates of food
consumption. Feeding efficiency (weight gain divided by
food intake) was not different between the groups between
9 weeks and the time of kill at 25 weeks suggesting that
overall energy balance was similar for 16 weeks prior to
kill (data not shown).
Hepatic mitochondrial enzyme activity, palmitate
oxidation and peroxisomal enzyme activity
β-HAD activity, the rate limiting enzyme for β-oxidation,
was 65% higher (P < 0.001) in the HCR livers
compared to LCR livers (Fig. 2A). Citrate synthase
activity and cytochrome c protein content, markers of
mitochondrial content, were 32–42% higher (P < 0.001)
in the HCR livers compared to LCR (Fig. 2B and
C). Immunoflourescence staining for CPS-1, a hepatic
mitochondrial marker, qualitatively revealed a greater
hepatic mitochondrial content in the HCR vs. the
LCR (Fig. 2D). The HCR mitochondria also had higher
rates of fatty acid oxidation than the LCR. Isolated
hepatic mitochondria from the HCR rats had a 63%
(Fig. 3A; P < 0.0001) higher rate of complete palmitate
oxidation to CO2 and a 22% higher (Fig. 3B; P < 0.001)
rate of total palmitate oxidation (CO2 + acid soluble
metabolite production) than the LCR. The LCR rats
also displayed significantly higher peroxisomal enzyme
activity for both acyl CoA oxidase (Fig. 4A; P = 0.039)
and catalase (Fig. 4B; P = 0.02) compared to the HCR
rats, suggestive of a compensatory increase in peroxisomal
activity due to reduced mitochondrial oxidative capacity.
Collectively these data show that LCR livers have both
a lower mitochondrial content and lower mitochondrial
oxidative capacity (decreased fatty acid oxidation per
mitochondria).
Hepatic lipogenesis
The content of SREBP-1c, a transcriptional regulator of
fatty acid synthesis genes (Shimano et al. 1996; Horton
et al. 2002), was significantly higher in the livers of LCR
rats than HCR rats (Fig. 5A). Specifically, SREBP-1c is
an upstream transcriptional regulator of both acetyl CoA
carboxylase (ACC) and fatty acid synthase (FAS). ACC
protein content, the enzyme responsible for malonyl CoA
production (a potent inhibitor of fatty acid oxidation and
the initial substrate for FAS), was 3-fold higher (P = 0.049)
in the LCR liver than the HCR liver (Fig. 5B). There
was no difference in serine79 phosphorylation of ACC
protein, a marker of ACC inhibition (data not shown),
suggesting that ACC differences were due to total content
of the enzyme and not due to differences in covalent
modification. We found no difference in FAS content
(Fig. 5C). Protein content of PPARγ and PPARα, vital
transcriptional regulators of lipid synthesis and oxidation
also were not different in the livers of LCR and HCR rats
(Fig. 5C).
Hepatic and extrahepatic lipid storage
Total hepatic TAG concentrations were significantly higher
in the LCR than the HCR rats (P = 0.02) (Fig. 1C). Within
the LCR rats, hepatic TAG levels inversely correlated
with maximum running distance (r = −0.724; P = 0.034),
demonstrating an influence of endurance capacity within
the LCR rat strain. The LCR livers also had a higher
steatosis score (P = 0.004) and >2 fold higher number
of hepatocytes associated with lipid droplets than the
HCR (Table 2 and Fig. 1). The adipocyte cell volumes
of both epidydimal and omental fat pads were 35%
(P = 0.003) and 50% (P = 0.025) larger in the LCR than
the HCR rats (Table 2). Although not measured herein, a
previous report has shown that total epididymal fat pad
weight is significantly higher in the LCR than HCR rats
(Noland et al. 2007a). Taken together, the LCR showed
both increased ectopic lipid storage in liver and expansion
of fat pads over the HCR.
Hepatic lipid peroxidation
LCR livers also displayed higher levels of lipid peroxidation
(4-HNE), a marker of oxidative stress, than HCR livers
(Fig. 1D (P = 0.04) (Western blot) and Fig. 1B (immuno-
histochemistry)) indicating that LCR livers possess both
increased lipids and oxidative stress early in life.
Hepatic injury
Staining for apoptotic hepatocytes revealed that the LCR
rats had a significantly higher percentage of apoptotic
nuclei than their HCR counterparts both at 25 weeks of
age (P < 0.001; data not shown) and after aging to natural
death (age at death ranged between 24 and 35 months)
(Fig. 6B; P = 0.007). Collagen deposition and fibrosis were
assessed by sirius red staining in formalin-fixed liver
sections. No visual fibrosis was detected from either group
at 25 weeks of age (data not shown); however, the LCR
livers display a greater percentage of fibrotic area than the
HCR rats after aging to natural death (Fig. 6A; P = 0.005).
These results suggest that early hepatic mitochondrial
defects in animals with low intrinsic aerobic capacity are
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associated with advanced disease development and hepatic
injury later in life.
Discussion
The major findings of this study are that intrinsically
low aerobic capacity in the LCR rats was associated
with reduced hepatic mitochondrial content, decreased
mitochondrial capacity to oxidize fatty acids, and an
increased hepatic de novo lipogenic profile. Furthermore,
the LCR rats developed hepatic steatosis by 25 weeks of
age and greater hepatic fibrosis and apoptosis at death
after natural aging compared to the HCR rats.
Low aerobic capacity, independent of physical activity
levels, is the best predictor of early mortality (Blair
et al. 1989; Myers et al. 2002) and is linked to type 2
diabetes (Mootha et al. 2003) and cardiovascular disease
(Myers et al. 2002). Recently, Church et al. (2006)
reported an inverse association between aerobic capacity
assessed by a graded exercise test and the prevalence of
NAFLD in a large cohort of male subjects, a finding that
also has been replicated in other studies (Nguyen-Duy
et al. 2003; McMillan et al. 2007). These studies suggest
that low aerobic capacity either directly impacts hepatic
metabolism or peripheral factors (insulin sensitivity or
Figure 1. Hepatic lipids
A, representative liver sections with H&E staining reveal
greater steatosis in the LCR livers than HCR. B,
representative liver sections of 4-HNE staining also show
greater lipid peroxidation in LCR livers. C, hepatic
triglyceride content is significantly higher in the LCR
than the HCR rats. D, lipid peroxidation quantified by
western blotting with 4-HNE antibody is significantly
higher in the LCR livers than HCR. Samples were
obtained from 25-week-old rats. ∗Significant difference
(P < 0.05); values are reported as means ± S.E.M.;
n = 7–8.
visceral adiposity) that lead to the increased storage of fat
in the liver. To our knowledge, there are no data describing
the hepatic biochemical/molecular adaptations that occur
in the livers of animals or humans with intrinsically low
or high aerobic capacity. Early reports and editorials on
the HCR/LCR model (Wisloff et al. 2005; Bernal-Mizrachi
& Semenkovich, 2006; Hawley & Spargo, 2006; Noland
et al. 2007a) postulated that LCR rats possessed low
rates of mitochondrial oxidative capacity in skeletal
muscle predisposing them to insulin resistance, obesity,
and metabolic complications, a common hypothesis
supported by studies in the skeletal muscle of humans
(Mootha et al. 2003; Petersen et al. 2004). We report
herein that intrinsically low aerobic capacity in sedentary
animals is also linked to decreased mitochondrial content
and mitochondrial oxidative capacity in liver, a phenotype
that we postulate leads to an increased susceptibility to
early life hepatic steatosis.
Mobilized fatty acids produced from the lipolysis of
visceral adipose are directly trafficked through the liver
via portal circulation making it no surprise that increased
visceral adiposity is strongly correlated to fatty liver
(Nguyen-Duy et al. 2003; Church et al. 2006; McMillan
et al. 2007). The LCR rats displayed increased expansion of
visceral fat (increased adipocyte cell volume of omental fat
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Figure 2. Hepatic mitochondrial content and enzyme activity
The activity of mitochondrial enzymes β-HAD (A) and citrate synthase (B) and the protein content of cytochrome
c (C) were significantly lower in the livers of LCR rats than HCR rats at 25 weeks of age. D, representative
immunofluorescence photomicrographs (magnification = 400×) for mitochondrial marker CPS1 (red) showed
granular staining patterns in liver sections. The LCR livers visibly display decreased CPS-1 staining compared to the
HCR at 25 weeks of age.
pad) along with a greater storage of hepatic fat compared
to the HCR, suggesting a connection between increased
visceral adiposity and fatty liver in this model. Excessive
daily food consumption and postprandial increases in
circulating lipids also contribute to excessive fat storage
in the liver and the expansion of visceral fat stores.
However, it is unlikely that increased food consumption
Figure 3. Hepatic mitochondrial fat oxidation
Both complete palmitate oxidation to CO2 (A) and total palmitate
oxidation (CO2 + ASM) (B) were significantly lower in isolated
mitochondria from the LCR rats than the HCR at 25 weeks of age.
∗Significant difference (P < 0.05); values are reported as
means ± S.E.M.; n = 7.
is the primary cause of excessive fat storage in the LCR
rats as the results presented here and in previous reports
(Noland et al. 2007a) show that the LCR actually have a
significantly lower (∼12–25%) daily food consumption
per body weight than the HCR. In summary, we post-
ulate that reduced hepatic mitochondrial oxidation is the
primary event mediating the increased fat deposition in
Figure 4. Hepatic peroxisomal activity
Hepatic peroxisomal enzyme activities of both acyl CoA oxidase (A)
and catalase (B) were significantly greater in LCR than HCR rats at
25 weeks of age. ∗Significant difference (P < 0.05); values are
reported as means ± S.E.M.; n = 7.
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the liver of the LCR although it is impossible to completely
discount the contributing effects of increased adiposity or
circulating insulin.
Aerobic capacity, hepatic mitochondrial oxidative
capacity and steatosis
Our research group and other labs have shown that
impaired hepatic fatty acid oxidation can be a primary
cause or strongly associated with fatty liver (Ibdah
et al. 2005; Rector et al. 2008); in contrast, others have
shown increased rates of hepatic fatty acid oxidation
in obese models of fatty liver disease (Brady et al.
1985; Sanyal et al. 2001; Miele et al. 2003). To explain
these divergent findings, it is hypothesized that increased
hepatic fatty acid oxidation is a secondary but insufficient
adaptation to a chronic oversupply of lipids to the
liver. Because of these conflicting results utilizing varied
methods, it is difficult to determine if hepatic fatty
acid oxidation differences are related to alterations in
hepatic mitochondrial fatty acid oxidation or if they
involve the extra-mitochondrial organelle, peroxisomes,
that boost fatty acid catabolism (Noland et al. 2007a).
PPARα is a transcription regulator of genes involved
in hepatic fatty acid oxidation, including mitochondrial
β-oxidation proteins (Memon et al. 2000). However,
hepatic PPARα also increases peroxisomal proliferation
and the capacity of peroxisomes to oxidize fatty acids
Figure 5. Hepatic lipid synthesis proteins
The protein content of SREBP-1c (A) and ACC (B) were significantly
higher in the livers of LCR than HCR rats. C, no differences were
observed for PPARα, PPARγ , or FAS protein contents between groups.
Representative western blots are shown. ∗Significant difference
(P < 0.05); values are reported as means ± S.E.M.; n = 7–8.
Table 2. Hepatic lipids and adipocyte cell volume
Variable LCR HCR
Steatosis score 2.20 ± 0.28∗ 1.17 ± 0.07
Hepatocytes with lipids (%) 54.0 ± 9.2∗ 22.0 ± 3.5
Epidydimal fat pad cell 160.0 ± 9.8∗ 118.4 ± 3.4
volume (pl)
Omental fat pad cell volume (pl) 122.3 ± 13.3∗ 85.7 ± 3.9
Means ± S.E.M. ∗Significantly different than HCR, P < 0.05;
pl, picolitres
(Reddy & Rao, 2006; Schoonjans et al. 1995; Schoonjans
et al. 1996). Hepatic PPARα protein content did not
differ between groups in our study. However, complete
hepatic mitochondrial fatty acid oxidation to CO2 and
total fatty acid oxidation (CO2 + ASM) was suppressed
in the LCR rats compared with the HCR, suggesting that
oxidative capacity of hepatic mitochondria is reduced in
LCR livers. In addition, the suppressed enzyme activity or
protein content at all three critical steps of mitochondrial
fat oxidation (β-oxidation, TCA cycle, and electron
transport) in the whole liver homogenate combined with
the reduced staining for CPS-1 strongly suggest that the
LCR livers also have lower mitochondrial content. In
agreement with Noland et al. (2007a), we also found no
differences in rates of hepatic fatty acid oxidation between
HCR and LCR rats when measurements were made in
whole liver homogenate (data not shown), a technique
that prevents the distinction between mitochondrial and
peroxisomal contributions. The lack of a significant
difference between groups using a liver whole homo-
genate suggested that LCR rats have a compensatory
increase in peroxisomal activity. Indeed, we found that the
LCR livers displayed higher peroxisomal activity (higher
acyl-CoA oxidase and catalase activity) than their HCR
counterparts. Increased peroxisomal activation can
contribute to significant lipid peroxidation or oxidative
stress, as acyl CoA oxidase produces hydrogen peroxide
(Reddy & Hashimoto, 2001). Taken together these results
clearly suggest that intrinsically low aerobic capacity
is associated with a reduced hepatic mitochondrial
quality and content and a compensatory increase in
peroxisomal activity. Importantly, a pathogenesis of
reduced mitochondrial oxidative capacity is documented
in patients with NAFLD making these findings clinically
relevant (Perez-Carreras et al. 2003).
It is impossible to completely eliminate the influence
of skeletal muscle mitochondrial function on the hepatic
phenotypes observed in the HCR and LCR rats, as the
model was created separating low and high running
capacity, a selective pressure largely dependent on the
function of skeletal muscle and the cardiorespiratory
system. It is possible that the lower levels of ambulatory
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Table 3. Physical activity, oxygen consumption and weekly food consumption
LCR HCR
Variable Dark Light 24 h Dark Light 24 h
Ambulatory activity (counts h−1) 345.5 ± 16.0∗ 78.7 ± 6.8∗ 216.7 ± 0.7∗ 573.4 ± 26.2 102.0 ± 4.7 345.8 ± 13.7
O2 consumption (ml kg–1 h–1) 1282.2 ± 36.4∗ 1042.1 ± 30.1∗ 1167.2 ± 34.8∗ 1532.7 ± 43.5 1176.0 ± 28.0 1362.7 ± 34.0
LCR HCR
Food consumption 52.05 ± 2.09∗ 58.79 ± 2.01
(g wk−1 per 100 g BW)
Mean ± S.E.M. ∗Significantly lower than HCR, P < 0.05; BW = body weight; ambulatory activity and O2 consumption were measured
over a 2 day period at 25 weeks of age. Average weekly food consumption was measured from 5 weeks of age (post-weaned) until
25 weeks of age.
physical activity witnessed in the LCR rats may have led to
reductions in hepatic mitochondrial content compared
to the HCR rats. This is unlikely as previous results
from our group studying far larger contrasting levels
Figure 6. Hepatic injury
Hepatic injury was greater in the LCR than the HCR rats when measured at the time of natural death. A, sirius red
staining for hepatic fibrosis (quantified by % of fibrotic area); B, apoptosis measured by TUNEL staining of apoptotic
hepatocytes nuclei. C, TGF-1β protein, a strong fibrogenic signal, was visually greater in livers from LCR than HCR
rats at the time of natural death. ∗Significant difference (P < 0.05); values are reported as means ± S.E.M.; n = 4–6.
of physical activity (daily voluntary wheel running at
a level of ∼6 km a day for 6 weeks vs. sedentary cage
only activity) caused no significant difference in hepatic
mitochondrial content in healthy rats (Laye et al. 2008).
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Our results clearly show that selective breeding for low
aerobic capacity resulted in lower hepatic mitochondrial
content and function in rats at 25 weeks of age, which we
speculate causes the increased susceptibility for hepatic
steatosis in the LCR rats. In support of this concept,
preliminary results from our laboratory show that the
phenotype of reduced lipid oxidation in the LCR livers is
retained in primary cell culture (data not shown). Just as
the selective breeding for low running capacity reduced
skeletal muscle mitochondrial ATP production needed
to fuel contractions, it also likely lowered the need for
hepatic mitochondrial ATP production, which is needed
to fuel the energy-costly process of gluconeogenesis
needed to maintain glucose homeostasis during
exercise.
Increased lipid peroxidation can lead to the production
of reactive aldehydes that damage mitochondrial DNA
(Demeilliers et al. 2002) or inactivate respiratory chain
proteins (Chen et al. 2000), resulting in reduced
mitochondrial content or function and hepatic injury.
Despite the strong link between obesity or aging and
reduced mitochondrial DNA in skeletal muscle, we were
unable to find studies linking hepatic lipid peroxidation
or oxidative stress to reduced liver mitochondrial DNA
that do not involve liver damage induced by alcohol or
pharmacological agents. Here we demonstrate that the
aging LCR rats have increased hepatic levels of lipid
peroxidation which is subsequent to reduced hepatic
mitochondrial function compared with the HCR rats.
This could be partially attributed to increased adiposity
(Noland et al. 2007a) and potentially greater hepatic
free fatty acid flux in the LCR animals. However, the
LCR rats had lower relative food consumption and
similar feed efficiencies compared to the HCR rats,
indicating similar energy balance between the two strains.
Collectively, these findings support our contention that
hepatic mitochondrial dysfunction plays a primary role
in non-alcoholic fatty liver disease development and
progression in animals with low intrinsic aerobic capacity.
Future studies are warranted to pair feed the two strains
and/or attempt to match ambulatory activity levels across
the lifespan.
Aerobic capacity, hepatic lipogenesis and steatosis
Both biochemical and histological measures showed
increased hepatic fat deposition in the LCR compared to
the HCR rats at 25 weeks of age. These findings contra-
dict an earlier report (Noland et al. 2007a) which studied
the effect of high fat diet on the metabolic phenotypes
of the HCR and LCR strains. That study did not find a
significant difference in hepatic fat storage between the
LCR and HCR strains on a normal chow or high-fat diet;
however, that study used the less sensitive and qualitative
Oil Red O technique to stain neutral lipids in a notably
small subset (n = 3) of liver samples, while our report used
the standard biochemical measure of hepatic triglycerides
in a larger sample size. In addition, rats were studied from
a different generation between the two studies (generation
13 in former report vs. generation 17 in this study) and it is
difficult to discern what impact further selective breeding
had upon metabolic or hepatic phenotypes. However, a
comparison of reports from previous generations shows
comparable values for both strains between generation
11 (Wisloff et al. 2005), 13 (Noland et al. 2007a), and
17 (this report) for measures of body weight, and serum
insulin and triglycerides suggesting that methodological
differences, and not generational differences, were the
main reason that hepatic triglycerides were not previously
reported to be higher in the LCR rats.
Insulin increases hepatic fatty acid synthesis, in part
through increases in SREBP-1c transcriptional regulation
of FAS and ACC (Shimomura et al. 1999). In the LCR
rats, it could be speculated that the elevated SREBP-1c
protein content was due to elevated serum insulin levels
resulting from peripheral insulin resistance (Noland et al.
2007a). The elevated SREBP-1c content in liver of LCR
rats was matched with a 2-fold higher protein content of
ACC over the HCR rat, with no observed differences in FAS
protein content or PPARγ. ACC synthesizes malonyl-CoA,
a metabolite that is both a substrate for de novo synthesis
of fatty acids through FAS and a potent inhibitor of fatty
acid oxidation (McGarry et al. 1977). Although malonyl
CoA was not measured herein, the elevated hepatic ACC
content also suggests that hepatic CPT-1 activity in the
LCR could allosterically be reduced due to a presumed
increase in hepatic malonyl-CoA levels.
In conclusion, these results show that the hepatic
phenotype associated with reduced aerobic capacity is
characterized by both reduced mitochondrial content
and oxidative capacity, leading to early hepatic steatosis
and lipid peroxidation and the later development of
elevated markers of liver injury. These findings provide
insight into the pathogenesis of hepatic steatosis and
may have important clinical implications. Lower intrinsic
aerobic capacity due to physical inactivity and/or genetic
heritability may lead to reduced hepatic mitochondrial
oxidative capacity and increased susceptibility to hepatic
steatosis and injury. Therefore, the clinical measurement
of aerobic capacity may serve as a valuable prognostic
tool. More importantly, because exercise training and/or
increased physical activity is the proven method to increase
aerobic capacity, it should remain the cornerstone therapy
for fatty liver disease.
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